Impact of different stages of chronic kidney disease on in-hospital costs in patients with coronary heart disease

Nephrology Dialysis Transplantation

Volumn 23, Issue 6, 2008, Pages 1955-1960

  Meyer, Anne ^a   Bunzemeier, Holger ^a   Hausberg, Martin ^a   Walter, Michael ^a   Roeder, Norbert ^a   Breithardt, Günter ^a   Reinecke, Holger ^a,b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Klinik und Poliklinik   (Germany)

Author keywords

Chronic kidney disease; Coronary heart disease; Costs; Mortality

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CORONARY BLOOD VESSEL; DATA BASE; DIABETES MELLITUS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HOSPITAL COST; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT CODING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMORBIDITY; CORONARY DISEASE; DIAGNOSIS-RELATED GROUPS; FEMALE; GERMANY; HOSPITAL COSTS; HUMANS; KIDNEY FAILURE, CHRONIC; LENGTH OF STAY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 38849180175     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm879     Document Type: Article

References (20)

1. US Renal Data System: USRDS Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes, and Digestive and Kidney Diseases, 2006
2. Hamer RA, El Nahas AM. The burden of chronic kidney disease. BMJ 2006; 332: 563-564
3. Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med 2006; 354: 997-999
4. Brosius FC III, Hostetter TH, Kelepouris E et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the young, and Epidemiology and prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation 2006; 114: 1083-1087
5. Levey AS, Andreoli SP, DuBose T et al. Chronic kidney disease: common, harmful, and treatable - World Kidney Day 2007. J Am Soc Nephrol 2007; 18: 374-378
6. Meguid El, Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005; 365: 331-340
7. Go AS, Chertow GM, Fan D. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
8. Anavekar NS, McMurray JJ, Velazquez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295
9. Reinecke H, Trey T, Matzkies F et al. Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. Kidney Int 2003; 63: 696-701
10. Furstenberg T, Rochell B, Roeder N et al. Ambulatory and hospital care in the Federal Republic of Germany. Am Heart Hosp J 2007; 5: 22-26
11. Furstenberg T, Bunzemeier H, Roeder N et al. Cardiovascular medicine in the German diagnosis-related group (G-DRG) system 2005. Z Kardiol 2005; 94: 360-370
12. Levey AS, Coresh J, Balk E et al. (National Kidney Foundation). National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147
13. Smith SC Jr, Dove JT, Jacobs AK et al. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001; 37: 2239i-lxvi
14. Institut für das Entgeltsystem im Krankenhaus. Leitlinien zur Kostenkalkulation. www.g-drg.de (only online available).
15. Smith DH, Gullion CM, Nichols G et al. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 2004; 15: 1300-1306
16. Gregory DD, Sarnak MJ, Konstam MA et al. Impact of chronic kidney disease and anemia on hospitalization expense in patients with left ventricular dysfunction. Am J Cardiol 2003; 92: 1300-1305
17. Ellis SG, Brown KJ, Ellert R et al. Cost of cardiac care in the three years after coronary catheterization in a contained care system: critical determinants and implications. J Am Coll Cardiol 1998; 31: 1306-1313
18. Selby JV, Ray GT, Zhang D et al. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care 1997; 20: 1396-1402
19. Favarato D, Hueb W, Gersh BJ et al. First year follow-up of MASS II study. Relative cost comparison of treatments for coronary artery disease: the first year follow-up of MASS II study. Circulation 2003; 108: II21-II23
20. Cohen DJ, Becker ER, Culler SD et al. Impact of patient characteristics, complications, and facility volume on the costs and time of cardiac catheterization and coronary angioplasty in 70 catheterization laboratories. Am J Cardiol 2000; 86: 595-601